Position in SGMOQ
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,582
-$6,342 QoQ
Shares Held
38,330
+1.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in SGMOQ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,582 | 38,330 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $15,924 | 37,918 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $26,737 | 39,907 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $23,312 | 43,172 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,933 | 52,930 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $51,423 | 50,416 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $52,256 | 60,066 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $23,388 | 64,973 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $90,018 | 134,357 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $92,288 | 170,905 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $194,801 | 324,671 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $451,193 | 347,073 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $905,304 | 514,378 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,257,484 | 400,473 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,185,394 | 445,999 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,968,490 | 475,481 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,393,515 | 584,082 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,535,278 | 604,704 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,917,892 | 656,814 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,261,656 | 690,197 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,256,704 | 658,955 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $12,348,756 | 791,080 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $8,023,236 | 849,020 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $7,296,941 | 814,391 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,262,401 | 669,137 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||